Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$36.12 - $41.79 $59,814 - $69,204
-1,656 Reduced 4.57%
34,589 $1.27 Million
Q1 2023

May 15, 2023

SELL
$39.39 - $51.28 $83,743 - $109,021
-2,126 Reduced 5.54%
36,245 $1.48 Million
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $669,085 - $873,417
-16,026 Reduced 29.46%
38,371 $1.97 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $172,676 - $210,795
-3,946 Reduced 6.76%
54,397 $2.38 Million
Q2 2022

Aug 15, 2022

SELL
$46.53 - $55.17 $422,073 - $500,447
-9,071 Reduced 13.46%
58,343 $3.06 Million
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $416,874 - $516,559
9,112 Added 15.63%
67,414 $3.49 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $2.41 Million - $3.57 Million
58,302 New
58,302 $3.44 Million
Q2 2021

Aug 13, 2021

SELL
$35.91 - $40.68 $254,960 - $288,828
-7,100 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$33.49 - $37.77 $1.58 Million - $1.79 Million
-47,300 Reduced 86.95%
7,100 $257,000
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $129,060 - $164,111
3,856 Added 7.63%
54,400 $2 Million
Q2 2020

Aug 14, 2020

BUY
$30.12 - $36.54 $29,276 - $35,516
972 Added 1.96%
50,544 $1.65 Million
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $264,785 - $378,321
-9,796 Reduced 16.5%
49,572 $1.62 Million
Q2 2018

Aug 14, 2018

BUY
$32.98 - $35.16 $34,266 - $36,531
1,039 Added 1.78%
59,368 $2.15 Million
Q1 2018

May 15, 2018

SELL
$31.91 - $37.02 $228,539 - $265,137
-7,162 Reduced 10.94%
58,329 $2.07 Million
Q4 2017

Feb 13, 2018

SELL
$33.26 - $35.29 $70,843 - $75,167
-2,130 Reduced 3.15%
65,491 $2.37 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $2.1 Million - $2.31 Million
67,621
67,621 $2.41 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $147B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Lombard Odier Asset Management (Europe) LTD Portfolio

Follow Lombard Odier Asset Management (Europe) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Europe) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Europe) LTD with notifications on news.